{"id":"W129265093","doi":"10.1182/blood.v122.21.4025.4025","title":"Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Failure With Imatinib Plus Dasatinib and/Or Nilotinib: 36-Month Update","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Internal medicine; Imatinib; Gastroenterology; Imatinib mesylate; Myeloid leukemia; Tyrosine-kinase inhibitor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002601173,0.0005810971,0.001131348,0.0008668239,0.000250088,0.001496746,0.0008948317,0.001841036,0.001633242],"category_scores_gemma":[0.002532472,0.0002338507,0.0008537333,0.001224556,0.0005407742,0.001355924,0.0004494244,0.002433571,0.0008543969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009159492,"about_ca_system_score_gemma":0.001251952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001033533,"about_ca_topic_score_gemma":0.003466546,"domain_scores_codex":[0.9994214,0.0001292629,0.000165379,0.00006988071,0.0001571543,0.00005703829],"domain_scores_gemma":[0.9974095,0.0009278909,0.0006066946,0.00005075168,0.0006995944,0.0003055139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0009488824,0.0003267445,0.003623144,0.0042543,0.0002650172,0.0008222001,0.000127297,0.0006269553,0.001492826,0.0009934632,0.07212779,0.9143913],"study_design_scores_gemma":[0.000743248,0.002381942,0.02075962,0.005330106,0.001110712,0.004866501,0.00022951,0.001250474,0.00107533,0.0007445633,0.9614397,0.00006826749],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.009928138,0.9709764,0.0008601926,0.01084476,0.002343026,0.00004875107,0.0003509916,0.00008577248,0.004561922],"genre_scores_gemma":[0.03608058,0.9438753,0.001563821,0.007427545,0.008113037,0.00007142104,0.000805853,0.00002929197,0.002033234],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002601173,"threshold_uncertainty_score":0.01375651,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01475420836809646,"score_gpt":0.2843805241773604,"score_spread":0.269626315809264,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}